The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our Deal Search Online database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry.

The largest deal of the week is Illumina, Inc.‘s acquisition of GRAIL for $8 billion. GRAIL was founded by Illumina in 2016 and was spun out as a standalone company raising $2 billion. The company uses Illumina’s NGS technology to develop data science and machine learning and create the atlas of cancer signals in the blood, enabling multi-cancer early detection tests. Illumina stockholders are expected to own approximately 93% of the combined company, while GRAIL stockholders are expected to own approximately 7%.

To subscribe to our Health Care M&A deals chart and more, visit our membership siteHealthCareMandA.com is devoted to healthcare merger and acquisition data for the serious analyst and investor. Every day, this service alerts you to developments in all the key segments of the health care service and technology markets.

Biotechnology  
AcquirerTargetPrice
Illumina, Inc.GRAIL$8,000,000,000
RocheInflazome$447,531,700
eHealth  
AcquirerTargetPrice
Halo Labs Inc.Cannafeels$4,880,872
Hospitals  
AcquirerTargetPrice
UMass Memorial Health CareHarrington HealthCare SystemN/A
Laboratories, MRI and Dialysis  
AcquirerTargetPrice
Ampersand Capital PartnersGeneWerk GmbHN/A
Ampersand Capital PartnersAmerican Laboratory Products Company, Ltd.N/A
Long-Term Care  
AcquirerTargetPrice
Atlas Senior Living3 assisted living communitiesN/A
Avanath Capital ManagementCascades Village Senior Apartments$27,150,000
Owner/operatorSterling Meadows$2,850,000
Pharmaceuticals  
AcquirerTargetPrice
PermiraNeuraxpharm Arzneimittel GmbH$1,880,000,000
Other Services  
AcquirerTargetPrice
Aoyuan Healthy Life Group Company LimitedZhejiang Liantianmei Corporate Management Company Limited$101,961,009
Thomas H. Lee Partners and Frazier Healthcare PartnersAdare PharmaceuticalsN/A
Odyssey Investment Partners, LLCProPharma GroupN/A
KKR & Co. L.P.1-800-CONTACTS, Inc.N/A
W20Elysia GroupN/A